Data pager
Data pager
12
 Item 1 to 20 of 27
of 2 
Show all 27
Start dateTitleDescriptionCityCountry
Data pager
Data pager
12
 Item 1 to 20 of 27
of 2 
Show all 27
15/09/2026Getting the CMC Dossier RightEnsure your CMC submissions meet current standards with this course, providing you with practical guidance on data expectations, common pitfalls, and best practices for preparing Module 3 of Marketing Authorisation Applications for synthetic molecules. Gain the insights needed to enhance compliance and streamline the approval process.LondonUnited KingdomCMCF2F26
15/09/2026Getting the CMC Dossier RightEnsure your CMC submissions meet current standards with this course, providing you with practical guidance on data expectations, common pitfalls, and best practices for preparing Module 3 of Marketing Authorisation Applications for synthetic molecules. Gain the insights needed to enhance compliance and streamline the approval process.Online CMCO26
16/09/2026Before the first clinical trial in humans (First-in-Human)Before the first clinical trial in humans (First-in-Human, FIH), there are many activities that need to be in place. During the evening, we will go through what is needed for CMC development for drugs and important factors when choosing a CDMO. What are the pre-clinical aspects that need to be documented in the form of in vitro, in vivo studies and safety studies. For medical devices, design control, risk analysis and pre-clinical tests are discussed. We also get to hear some news about TOPRA. You will have the opportunity to meet colleagues in a relaxed and pleasant environment. The meeting is open to everyone who works with and is interested in regulatory affairs.LundSwedenSWESEP26
22/09/2026Essentials of European Medical Device Regulatory AffairsLearn the essentials of European medical device regulations in this practical, interactive, and career-boosting one-day course.LondonUnited KingdomBASMD0926F
05/10/2026Artifical Intelligence in Regulatory AffairsHosted by TOPRA IN Sweden, this is an excellent opportunity to come together and explore how artificial intelligence (AI) is reshaping regulatory work in the life sciences. Over the course of the evening, we'll look at how AI can streamline workflows, strengthen the quality of regulatory documentation and support smarter strategic decision-making, alongside the governance, data quality and compliance considerations that come with it. We'll also hear the very latest news from TOPRA. Whether you work in pharmaceuticals or medical devices, and whether you're a seasoned regulatory professional or newer to the field, we'd love to see you there.UppsalaSwedenSWEOCT26
06/10/2026Regulatory Strategy in the Post Market PhaseGain the strategic insight needed to protect compliance, manage risk, and sustain the commercial success of medical devices throughout the post-market phase. This course is also Module 17 of the MSc programme.LondonUnited KingdomMSCMD1726F
06/10/2026Regulatory Strategy in the Post Market PhaseGain the strategic insight needed to protect compliance, manage risk, and sustain the commercial success of medical devices throughout the post-market phase. OnlineMSCMD1726O
06/10/2026Structured Content, Managed Data and AIJoin cormeo's webinar, hosted by TOPRA, to see how structured content and connected data can transform regulatory information management. Static, document-based systems can slow processes and increase compliance risk. Discover cormeo's vision, alongside its brands EXTEDO, Docuvera, Rote Liste and medicines.ie, for moving beyond disconnected files and manual processes: structured components, master data and submissions flowing through streamlined workflows to successful health agency approval. Free for TOPRA members. OnlineCORM092026
09/10/2026Intelligence To Impact: Becoming a Strategic FunctionAs the regulatory landscape becomes increasingly complex, dynamic, and globally interconnected, Regulatory Intelligence is evolving beyond regulatory monitoring into a strategic function that supports proactive decision-making, risk management, and business success across the product lifecycle. OnlineREGINTEL10
13/10/2026Understanding Clinical DevelopmentDevelop a clear understanding of how effective clinical trials are designed, drawing on practical perspectives from regulators and industry. This course addresses key considerations for planning and conducting clinical trials from phase I through phases II and III, and for supporting regulatory expectations beyond initial marketing approval.Online CD26O
13/10/2026Understanding Clinical DevelopmentDevelop a clear understanding of how effective clinical trials are designed, drawing on practical perspectives from regulators and industry. This course addresses key considerations for planning and conducting clinical trials from phase I through phases II and III, and for supporting regulatory expectations beyond initial marketing approval.LondonUnited KingdomCUCDF2F26
15/10/2026Essentials of European Pharmaceutical Regulatory AffairsThis course offers a basic but comprehensive understanding of European pharmaceutical regulatory affairs in a relaxed and interactive environment. Learn from industry experts and gain practical insights you can apply in your role.OnlineOnlineBAS1026O
19/10/2026Human Medicines Symposium 2026Join us at the forefront of regulatory affairs at the TOPRA Human Medicines Symposium 2026. Hear from industry leaders, engage in interactive discussions, and explore the latest developments and challenges shaping the sector from both regulatory and industry perspectives. Expand your expertise and take away strategies to drive innovation in your organisation.UtrechtNetherlandsHSYMP2026
19/10/2026Medical Devices/IVDs Symposium 2026The regulation of medical devices is continually changing as more innovative technologies and drug–device combinations are being developed. Anyone involved in medical devices and in vitro diagnostics (IVDs) needs to keep up to date with both the new EU regulations and the clinical requirements. In 2026, the programme will increase to three full days, providing even more opportunities to learn and engage.UtrechtNetherlandsMDSYMP2026
19/10/2026Veterinary Medicines Symposium 2026The Veterinary Medicines Symposium will concentrate on how we can improve animal health with veterinary medicines by looking at how we collaborate now and in the future, what strategies could be put in place and how we can work together towards new solutions.UtrechtNetherlandsVETSYM2026
20/10/2026SME Symposium 2026Small and medium sized companies (SMEs) face different regulatory challenges when developing the life science products of the future that meet patients’ needs. This Symposium stream will explore the key regulatory topics that impact SMEs and for 2026, the stream has been extended to 1.5 days, giving you the opportunity to take part in more sessions, join deeper discussions, and make the most of valuable networking time with your fellow conference delegates.UtrechtNetherlandsSME2026
28/10/2026European MedTech Market: One Approval Isn’t EnoughDA approval often creates a false sense of readiness for MedTech companies entering Europe, where underestimating regulatory and clinical differences leads to Notified Body delays, evidence gaps, and unpredictable timelines under MDR and IVDR. Building on QbD Group's Landing in Europe whitepaper, this webinar explains why EU entry demands a different approach, covering clinical evidence expectations, Notified Body interactions, and the full lifecycle from gap assessment to CE marking and post-market compliance. Register to assess your true EU readiness, avoid costly delays, and learn what it really takes to succeed in Europe. OnlineQBDOCT26
03/11/2026Overview of EU and UK Regulatory AffairsGain a comprehensive introduction to the pharmaceutical development pathway and the EU and UK regulatory systems that support it, with insight into the essential contribution regulatory affairs makes across the lifecycle of a medicine. This course is also Module 0 of the MSc programme.ViennaAustriaIC22026F
03/11/2026Overview of EU and UK Regulatory AffairsGain a comprehensive introduction to the pharmaceutical development pathway and the EU and UK regulatory systems that support it, with insight into the essential contribution regulatory affairs makes across the lifecycle of a medicine. OnlineIC22026O
03/11/2026Prescription To Non-Prescription Medicines Switch in EUNavigating the Rx to OTC switch process in Europe takes more than regulatory knowledge. It requires strategy, market awareness and the ability to turn theory into action. This course equips you with all three, combining a thorough grounding in EU frameworks with practical case studies so you can apply what you learn from day one.Online CREDPNP26O